Thermal, dynamic and structural properties of drug AT 1 antagonist olmesartan in lipid bilayers

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 12, 2011, Pages 2995-3006

  Ntountaniotis, Dimitrios ^a,b   Mali, Gregor ^c,d   Grdadolnik, Simona Golic ^c,d   Maria, Halabalaki ^e   Skaltsounis, Alexios Leandros ^e   Potamitis, Constantinos ^b   Siapi, Eleni ^b   Chatzigeorgiou, Petros ^e   Rappolt, Michael ^f   Mavromoustakos, Thomas ^e  

^a UNIVERSITY OF PATRAS   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

^c NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^d EN FIST CENTRE OF EXCELLENCE   (Slovenia)

^e UNIVERSITY OF ATHENS   (Greece)

^f SINCROTRONE TRIESTE   (Italy)

Author keywords

Differential scanning calorimetry; Dipalmitoyl phosphatidylcholine bilayer; Olmesartan; Raman spectroscopy; Small angle and wide angle X ray scattering; Solid state NMR spectroscopy

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; OLMESARTAN;

ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG STRUCTURE; HYDROPHOBICITY; LIPID BILAYER; MEMBRANE FLUIDITY; MEMBRANE VESICLE; MOLECULAR SIZE; PRIORITY JOURNAL; THERMODYNAMICS;

CALORIMETRY, DIFFERENTIAL SCANNING; IMIDAZOLES; LIPID BILAYERS; MAGNETIC RESONANCE SPECTROSCOPY; RECEPTOR, ANGIOTENSIN, TYPE 2; SCATTERING, RADIATION; SPECTRUM ANALYSIS, RAMAN; TETRAZOLES;

EID: 84860390562     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2011.08.001     Document Type: Article

References (87)

1. A.M. Bell, and D. Nykamp Hypertension: focus on olmesartan medoxomil clinical medicine Therapeutics 1 2009 1 9
2. A. Ferro, R. Gilbert, and H. Krum Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition Int. J. Clin. Pract. 60 5 2006 577 581
3. K.S. Babu, A.R. Tagore, G.S. Reddy, G. Venkateswarlu, P.P. Reddy, and R.V. Anand Synthesis of related substances of olmesartan medoxomil, anti-hypertensive drug Arkivoc II 2010 292 302
4. 1 receptor: conformational analysis, dynamic NMR spectroscopy, in silico docking and molecular dynamics simulations J. Chem. Inf. Model. 49 2009 726 739
5. M. Burnier Angiotensin II type 1 receptor blockers Circulation 103 2001 904 912 (Pubitemid 32163892)
6. M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, and T. Unger International union of pharmacology. XXIII. The angiotensin II receptors Pharmacol. Rev. 52 3 2000 415 472
7. R.M. Touyz Intracellular mechanisms involved in vascular remodeling of resistance arteries in hypertension: role of angiotensin II Exp. Physiol. 90 2005 449 455 (Pubitemid 40980144)
8. H. Kobori, N. Masaomi, G. Navar, and A. Nishiyama The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease Pharmacol. Rev. 59 3 2007 251 287 (Pubitemid 47481436)
9. Y. Kyotani, J. Zhao, S. Tomita, H. Nakayama, M. Isosaki, M. Uno, and M. Yoshizumi Olmesartan inhibits angiotensin II-induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways J. Pharmacol. Sci. 113 2010 161 168
10. T. Murakami, H. Konno, N. Fukutsu, M. Onodera, T. Kawasaki, and F. Kusu Identification of a degradation product in stressed tablets of olmesartan medoxomil by the complementary use of HPLC hyphenated techniques J. Pharm. Biomed. Anal. 47 2008 553 559
11. D.E. Mire, T.N. Silfani, and M.K. Pugsley A review of the structural and functional features of olmesartam medoxomil, an angiotensin receptor blocker J. Cardiovasc. Pharmacol. 46 5 2005 585 593 (Pubitemid 41527750)
12. M.A.M. Gomes, A.D. de Magalhães Feitosa, W. Oigman, J.M. Ribeiro, E.H. Moriguchi, J.F.K. Saraiva, D.B. Précoma, A.B. Ribeiro, C. Amodeo, and A.A. Brandão Based treatment algorithm for essenssial hypertension with olmesartan medoxomil Arq. Bras. Cardiol. 91 3 2008 168 176
13. L.M. Ruilope Clinical efficacy and safety of olmesartan/ hydrochlorothiazide combination therapy in patients with essential hypertension Vasc. Health Risk Manag. 4 6 2008 1237 1248
14. M. Greathouse Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension Vasc. Health Risk Manag. 2 4 2006 401 409 (Pubitemid 46231271)
15. D. Norwood, E. Branch, B. Smith, and M. Honeywell Olmesartan medoxomil for hypertension: a clinical review Pharm. Ther. 27 2002 611 618 (Pubitemid 38075857)
16. P. Mehulkumar, V. Ramesh, V. Vinay kumar, R. Srinivas, and V. Diwan Prakash Simultaneous spectroscopic estimation of amlodipine besylate and olmesartan medoximil in tablet dosage form Asian J. Res. Chem. 2 2 2009 127 130
17. Daiichi Sankyo, Inc. TRIBENZOR Prescribing Information.
18. M.A. Adams, and L. Trudeau Irbesartan: review of pharmacology and comparative properties Can. J. Clin. Pharmacol. 7 1 2000 22 31 (Pubitemid 30232667)
19. 1 receptor Chem. Phys. Lipids 125 1 2003 13 25 (Pubitemid 37414802)
20. M. Paul, A.P. Mehr, and R. Kreutz Physiology of local renin-angiotensin systems Physiol. Rev. 86 2006 747 803 (Pubitemid 44033382)
21. L. Zhao, S.S. Feng, N. Kocherginsky, and I. Kostetski DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane Int. J. Pharm. 338 2007 258 266 (Pubitemid 46783980)
22. S. Fujisawa, M. Ishihara, and Y. Kadoma pH-dependent complexation of methacryloyloxydecyl dihydrogen phosphate (MDP) with dipalmitoyl-phosphatidyl- choline (DPPC) liposomes: DSC and NMR measurements Internet Electron. J. Mol. Des. 5 2006 49 59
23. K. Wójtowicz Comparison of the effect of 4-hydroxycoumarin and umbelliferone on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers Pharmacol. Rep. 60 2008 555 560
24. F. Castelli, C. Messina, M.G. Sarpietro, R. Pignatello, and G. Puglisi Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments AAPS PharmSciTech 3 2 2002 (article 9)
25. M.C. Sainz, J.R. Chantres, B. Elorza, and M.A. Elorza DSC study of the action of phenylbutazone on DMPC and DPPC bilayers Int. J. Pharm. 89 3 1993 183 190 (Pubitemid 23067152)
26. T. Mavromoustakos The use of differential scanning calorimetry to study drug-membrane interactions Alex M. Dopico, Methods Molecular Biology 400 2007 Humana Press 587 600 (Pubitemid 350183716)
27. A. Hodzic, M. Rappolt, H. Amenitsch, P. Laggner, and G. Pabst Differential modulation of membrane structure and fluctuations by plant sterols and cholesterol Biophys. J. 94 2008 3935 3944
28. J. Pan, T.T. Mills, S. Tristram-Nagle, and J.F. Nagle Cholesterol perturbs lipid bilayers nonuniversally Phys. Rev. Lett. 100 19 2008 198103
29. A. Ramamoorthy, D.K. Lee, T. Narasimhaswamy, and R.P.R. Nanga Cholesterol reduces pardaxin's dynamics - a barrel-stave mechanism of membrane disruption investigated by solid-state NMR Biochim. Biophys. Acta 1798 2010 223 227
30. U. Holzgrabe, I. Wawer, and B. Diehl NMR Spectroscopy in Pharmaceutical Analysis First ed. 2008 Elsevier
31. 31P solid-state NMR study Biophys. Chem. 120 2006 178 187
32. T. Mavromoustakos, and I. Daliani Effects of cannabinoids in membrane bilayers containing cholesterol Biochim. Biophys. Acta 1420 1999 252 265 (Pubitemid 29369036)
33. 31P-nuclear magnetic resonance spectroscopy with differential scanning calorimetry to study cannabinoid-membrane interactions Chem. Phys. Lipids 92 1998 37 52 (Pubitemid 28236433)
34. T. Mavromoustakos, P. Chatzigeorgiou, C. Koukoulitsa, and S. Durdagi Partial interdigitation of lipid bilayers Int. J. Quantum Chem. 6 2011 1172 1183
35. H. Amenitsch, M. Rappolt, M. Kriechbaum, H. Mio, P. Laggner, and S. Bernstorff First performance assessment of the small-angle X-ray scattering beamline at ELETTRA J. Synchrotron Radiat. 5 1998 506 508
36. S. Bernstorff, H. Amenitsch, and P. Laggner High-throughput asymmetric double-crystal monochromator of the SAXS beamline at ELETTRA J. Synchrotron Radiat. 5 1998 1215 1221
37. A.M. Petrascu, M.H.J. Koch, and A. Gabriel A beginners' guide to gas-filled proportional detectors with delay line readout J. Macromol. Sci. B 37 1998 463 483 (Pubitemid 128495079)
38. T.C. Huang, H. Toraya, T.N. Blanton, and Y. Wu X-ray powder diffraction analysis of silver behenate, a possible low-angle diffraction standard J. Appl. Crystallogr. 26 1993 180 184
39. K. Ohkura, S. Kashino, and M. Haisa Crystal structure of p-bromobenzoic acid Bull. Chem. Soc. Jpn. 45 1972 2651 2653
40. M. Rappolt, A. Hodzic, B. Sartori, M. Ollivon, and P. Laggner Conformational and hydrational properties during the Lbeta to Lalpha and Lalpha to HII-phase transition in phosphatidylethanolamine Chem. Phys. Lipids 154 2008 46 55
41. M. Rappolt The biologically relevant lipid mesophases as "seen" by X-rays A. Leitmannova-Liu, Advances in Planar Lipid Bilayers and Liposomes vol. 5 2006 Elsevier Inc. Amsterdam 253 283 (Pubitemid 351970320)
42. G. Pabst, M. Rappolt, H. Amenitsch, and P. Laggner Structural information from multilamellar liposomes at full hydration: full q-range fitting with high-quality X-ray data Phys. Rev. E 62 2000 4000 4009
43. M. Rappolt Bilayer thickness estimations with "poor" diffraction data J. Appl. Phys. 107 084701 2010 1 7
44. 2H nuclear magnetic resonance and differential scanning calorimetry Biochemistry 29 1990 451 464 (Pubitemid 20037653)
45. A. Ramamoorthy Beyond NMR spectra of antimicrobial peptides: dynamical images at atomic resolution and functional insights Solid State Nucl. Magn. Reson. 35 2009 201 207
46. W. Guo, and J.A. Hamilton A multinuclear solid-state NMR study of phospholipid-cholesterol interactions. Dipalmitoylphosphatidylcholine- cholesterol binary system Biochemistry 34 1995 14174 14184
47. 13C CPMAS NMR study Arkivoc IV 2008 33 46
48. R.C. Spiker, and I.W. Levin Raman spectra and vibrational assignments for dipalmitoylphosphatidylcholine and structurally related molecules Biochim. Biophys. Acta 388 1975 361 373
49. N. Yellin, and I.W. Levin Hydrocarbon chain disorder in lipid bilayers: temperature dependent Raman spectra of 1,2-diacylphosphatidylcholine-water gels Biochim. Biophys. Acta 489 1977 177 190 (Pubitemid 8220198)
50. N. Yellin, and I.W. Levin Hydrocarbon chain trans-gauche isomerization in phospholipid bilayer gel assemblies Biochemistry 16 1977 642 647 (Pubitemid 8047802)
51. C.B. Fox, R.H. Uibel, and J.M. Harris Detecting phase transitions in phosphatidylcholine vesicles by Raman microscopy and self-modeling curve resolution J. Phys. Chem. B 111 2007 11428 11436 (Pubitemid 47598324)
52. M. Rappolt, P. Laggner, and G. Pabst Structure and elasticity of phospholipid bilayers in the La phase: a comparison of phosphatidylcholine and phosphatidylethanolamine membranes S.G. Pandalai, Recent Research Developments in Biophysics vol. 3 2004 Transworld Research Network Trivandrum 365 394 Part II
53. M.H.F. Wilkins, A.E. Blaurock, and D.M. Engelman Bilayer structure in membranes Nat. New Biol. 230 1971 72 76
54. S. Tristram-Nagle, R. Zhang, R.M. Suter, C.R. Worthington, W.J. Sun, and J.F. Nagle Measurement of chain tilt angle in fully hydrated bilayers of gel phase lecithins Biophys. J. 64 1993 1097 1109 (Pubitemid 23143274)
55. M.J. Ruocco, and G.G. Shipley Characterization of the sub-transition of hydrated diplmitoyolphosphatidylcholine bilayers. Kinetic, hydration and structural study Biochim. Biophys. Acta 691 1982 309 320
56. W.J. Sun, R.M. Suter, M.A. Knewtson, C.R. Worthington, S. Tristram-Nagle, R. Zhang, and J.F. Nagle Order and disorder in fully hydrated unoriented bilayers of gel phase dipalmitoylphosphatidylcholine Phys. Rev. E 49 1994 4665 4676
57. W.J. Sun, S. Tristram-Nagle, R.M. Suter, and J.F. Nagle Structure of the ripple phase in lecithin bilayers Proc. Natl. Acad. Sci. U. S. A. 93 1996 7008 7012 (Pubitemid 26243491)
58. M. Rappolt, and G. Rapp Structure of the stable and metastable ripple phase of dipalmitoylphosphatidylcholine Eur. Biophys. J. 24 1996 381 386 (Pubitemid 26249047)
59. J.F. Nagle, and S. Tristram-Nagle Structure of lipid bilayers Biochim. Biophys. Acta 1469 2000 159 195
60. J. Katsaras, S. Tristram-Nagle, Y. Liu, R.L. Headrick, E. Fontes, P.C. Mason, and J.F. Nagle Clarification of the ripple phase of lecithin bilayers using fully hydrated, aligned samples Phys. Rev. E 61 2000 5668 5677
61. T.P. McMullen, and R.N. McElhaney New aspects of the interaction of cholesterol with dipalmitoylphosphatidylcholine bilayers as revealed by high-sensitivity differential scanning calorimetry Biochim. Biophys. Acta 1234 1995 90 98
62. M. Rappolt, M.F. Vidal, M. Kriechbaum, M. Steinhart, H. Amenitsch, S. Bernstorff, and P. Laggner Structural, dynamic and mechanical properties of POPC at low cholesterol concentration studied in pressure/temperature space Eur. Biophys. J. 31 2003 575 585 (Pubitemid 36286320)
63. G. Pabst, H. Amenitsch, D.P. Kharakoz, P. Laggner, and M. Rappolt Structure and fluctuations of phosphatidylcholines in the vicinity of the main phase transition Phys. Rev. E 70 2004 021908-1 021908-9
64. G. Pabst, J. Katsaras, V.A. Raghunathan, and M. Rappolt Structure and interactions in the anomalous swelling regime of phospholipid bilayers Langmuir 19 2003 1716 1722
65. M. Rappolt, and G. Rapp Simultaneous small- and wide-angle X-ray diffraction during the main transition of dimyristoylphosphatidylethanolamine Ber. Bunsenges. Phys. Chem. 100 1996 1153 1162 (Pubitemid 126752769)
66. E. Theodoropoulou, and D. Marsh Interactions of angiotensin II non-peptide AT(1) antagonist losartan with phospholipid membranes studied by combined use of differential scanning calorimetry and electron spin resonance spectroscopy Biochim. Biophys. Acta 1461 1 1999 135 146 (Pubitemid 30077469)
67. C. Fotakis, D. Christodouleas, P. Zoumpoulakis, A. Gili, E. Kritsi, N.P. Benetis, M. Zervou, H. Reis, M. Papadopoulos, and T. Mavromoustakos Comparative biophysical studies of sartan class drug molecules losartan and candesartan (CV-11974) with membrane bilayers J. Chem. Phys. B 115 19 2011 6180 6192
68. C. Fotakis, S. Gega, E. Siapi, C. Potamitis, K. Viras, P. Moutevelis-Minakakis, G. Kokotos, S. Durdagi, S. Grdadolnik, B. Sartori, M. Rappolt, and T. Mavromoustakos Drug interactions at the bilayer interface and receptor site induced by the novel synthetic pyrrolidinone analog MMK3 Biochim. Biophys. Acta 1798 3 2010 422 432
69. 2H NMR Biochim. Biophys. Acta 1808 9 2011 2095 2101
70. I. Tadeusz, A. Gumieniczek, and A. Kasinska Chromatographic evaluation of lipophilicity for angiotensin II AT1 receptor antagonists Annales Universitatis Marie Curie-Sklodowska Lublin-Polonia 21(1) 2008 23 29
71. T. Mavromoustakos, E. Theodoropoulou, and De-Ping Yang The use of high resolution solid-state NMR spectroscopy and differential scanning calorimetry to study interactions of anaesthetic steroids with membrane Biochim. Biophys. Acta 1328 1997 65 73 (Pubitemid 27344898)
72. 16-analog on the thermotropic properties of membrane bilayers. A model for membrane perturbation Biochim. Biophys. Acta 1239 1995 257 264
73. J.S. Santos, D.K. Lee, and A. Ramamoorthy Effects of antidepressants on the conformation of phospholipid headgroups studied by solid-state NMR Magn. Reson. Chem. 42 2004 105 114 (Pubitemid 38178078)
74. T.J. O'Leary, P.D. Ross, and I.W. Levin Effects of anesthetic and non anesthetic steroids on dipalmitoylphosphatidylcholine liposomes: a calorimetric and Raman spectroscopic investigation Biochemistry 23 1984 4636 4641 (Pubitemid 14012276)
75. C. Potamitis, P. Chatzigeorgiou, E. Siapi, T. Mavromoustakos, A. Hodzic, F. Cacho-Nerin, P. Laggner, and M. Rappolt Interactions of the AT1 antagonist valsartan with dipalmitoyl-phosphatidylcholine bilayers Biochim. Biophys. Acta 1808 2011 1753 1763
76. N.B. Colthulp, L.H. Daly, and S.E. Wiberley Introduction to Infrared and Raman Spectroscopy 1990 Academic Press
77. I.W. Levin, and R.N. Lewis Fourier transform Raman spectroscopy of biological materials Anal. Chem. 62 1990 1101A 1111A
78. R.K. Bista, R.F. Bruch, and A.M. Covington Variable-temperature Raman spectro-microscopy for a comprehensive analysis of the conformational order in PEGylated lipids J. Raman Spectrosc. 40 2008 463 471
79. B.P. Gaber, and W.L. Peticolas On the quantitative interpretation of biomembrane structure by Raman spectroscopy Biochim. Biophys. Acta 465 1977 260 274 (Pubitemid 8047277)
80. 31P NMR methodology to study the possible interdigitation effect of losartan in phospholipids bilayers. Comparison with Raman spectroscopy data Biophys. J. 96 2009 2227 2236
81. 31P CP NMR multilamellar bilayer broadlines in the absence and presence of the bioactive dipeptide beta-Ala-Tyr or Glu Chem. Phys. 314 1-3 2005 57 72 (Pubitemid 40630999)
82. I. Kyrikou, S. Xadjikakou, D. Kovala-Demertzi, K. Viras, and T. Mavromoustakos Effects of non steroid anti-inflammatory drugs in membrane bilayers containing cholesterol Chem. Phys. Lipids 132 2004 157 169 (Pubitemid 39536141)
83. E. Bicknell-Brown, and K.G. Brown Raman temperature study of conformational changes in anhydrous dipalmitoylphosphatidylcholine Biochim. Biophys. Acta 778 1984 317 323
84. A.L. Jenkins, R.A. Larsen, and T.B. Williams Characterization of amino acids using Raman spectroscopy Spectrochim. Acta A 61 2005 1585 1594 (Pubitemid 40455310)
85. R. Nakagomi-Hagihara, D. Nakai, K. Kawai, Y. Yoshigae, T. Tokui, T. Abe, and T. Ikeda OATP1B1, OATP1B3, and MRP2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker Drug Metab. Dispos. 34 2006 862 869
86. E. Cagigal, L. Gonzalez, R.M. Alonso, and R.M. Jimenez pKa determinination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry J. Pharm. Biomed. Anal. 26 2001 477 486 (Pubitemid 32727666)
87. T. Kikuchi, N. Ito, M. Suzuki, A. Kusai, K. Iseki, and H. Sasaki Self-association properties of 4-[1-hdyroxy-1-methylethyl]-2-propyl-1-[4- [tetrazole-5yl]phenyl]phenyl]methylimidazole-5-carboxylic acid monohydrate (CS-0880, an antiglaucoma ophthalmic agent Int. J. Pharm. 299 2005 100 106 (Pubitemid 40962411)